Prelude Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-33,943
| Closed | -$868K | – | 1802 |
|
|
2021
Q1 | $868K | Buy |
+33,943
| New | +$868K | 0.02% | 405 |
|
|
2020
Q4 | – | Sell |
-200
| Closed | -$4K | – | 1775 |
|
|
2020
Q3 | $4K | Sell |
200
-3,300
| -94% | -$66K | ﹤0.01% | 1211 |
|
|
2020
Q2 | $89K | Buy |
+3,500
| New | +$89K | ﹤0.01% | 682 |
|
|
2017
Q2 | – | Sell |
-1,200
| Closed | -$4K | – | 1857 |
|
|
2017
Q1 | $4K | Buy |
1,200
+900
| +300% | +$3K | ﹤0.01% | 1360 |
|
|
2016
Q4 | $1K | Buy |
+300
| New | +$1K | ﹤0.01% | 1457 |
|